Both left ventricle hypertrophy and dilation were significant and associated with systolic hypertension and anaemia.
INTRODUCTION
Cardiovascular disease is highly prevalent among end stage renal disease (ESRD) patients. It accounting for about 42% of all fatalities among haemodialysis patients. Pre-existing cardiovascular diseases are present in more than 50% of patients starting haemodialysis program (2) . Patients with chronic renal failure become exposed to hemodynamic stress that cause vascular and ventricular alteration which increase ventricular mass and later associated with cardiovascular morbidity and mortality (3) .
Patients with ESRD become exposed to traditional as well as uremic, nonatherosclerotic risk factors, including LVH and fibrosis for left ventricular dysfunction. In uremic patient left ventricular abnormalities results from both LV pressure over load and LV volume overload, leading to myocyte death and increasing myocardial fibrosis, decreasing coronary perfusion which may become manifested as left ventricular diastolic dysfunction or may progress to left ventricular systolic dysfunction (3) (4) (5) . Left ventricular pressure overload factors can result from systemic arterial resistance, elevated arteria systolic and diastolic blood pressure and large vessels compliance (6) leading to increase in left ventricular mass, relative wall thickness and decrease in left ventricular volume. Left ventricular dilatation and eccentric hypertrophy is caused by volume, preload factors including salt and fluid loading, anaemia, and large flow arterio-venous fistula (3) .
Left ventricular hypertrophy is a histological diagnosis, but biopsy is not always applicable and other investigations are used for diagnosis. This may include invasive measurement as well as other expensive one with limited availability like magnetic resonance imaging, the "gold standard" technique, and cine cardiac computed tomography (7) . For research purpose, an echocardiography is usually used. Echocardiography is a simple, noninvasive, and accurate test which is extremely useful in assessment of left ventricular function in dialysis patient. Baseline, at start of dialysis program and serial echocardiography is needed for chronic renal failure patients on maintenance haemodialysis (8) . M-mode and two dimensional echocardiography allow assessment of ventricular mass and volume for diagnosis of hypertrophy, its geometrical pattern and systolic function.
Conventionally, thrice weekly haemodialysis session program is usually offered for ESRD patients, but in some developing countries, including Yemen, due to some limitation of the available haemodialysis machines, patient received only twice weekly 3-4 hourly each of haemodialysis session program (9) . Assessment of left ventricular function amongst ESRD in Aden, Yemen is lacking and this could lead to that health need of these patients being neglected.
The present study aims were as follows: 1) to describe the characteristic of patients with ESRD on maintenance haemodialysis in two centres in Aden, Yemen and 2) to assess the cardiac status, specifically, left ventricle in these patients and to explore factors associated with left ventricular abnormalities. In the light of absence of past studies assessing the cardiac status of Yemeni patients attending ESRD in Aden, Yemen an open-ended approach was adopted with respect to any prior hypotheses testing.
METHODS

Study design, participants' recruitment and setting
A cross sectional study was performed on 105 patients with end stage renal disease (ESRD) on maintenance haemodialysis in two haemodialysis centers in Aden, Yemen. The study was carried out during a period from November 2013 and early March 2014.
Patients' inclusion and exclusion criteria
All adult Yemeni (18 years and older) patients received twice weekly 4 hours each of haemodialysis sessions with duration of haemodialysis of more than 3 months were included.
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Patients who did not meet the aforementioned inclusion criteria and refused echo-study were excluded from this study.
Variables
These included items about socio-demographic characteristics of patients (age, sex, marital state, occupation), in addition, duration of haemodialysis, health condition (s) and access to haemodialysis (e.g. A-V fistula). Clinical data were obtained from patients file or directly from patients. Measurement of weight and height and calculation of body surface area (BSA)
were assessed. Blood pressure measurements were carried out by a trained nurse prior to haemodialysis. A mercury sphygmomanometer was used in the contra-lateral arm in patient with A-V fistula.
An average value of a three consecutive reading during three haemodialysis session Two D echocardiography was used to evaluate valve structure including valve calcification. Heart valve calcification was defined as the presence or absence of aortic and mitral valve bright echo-calcification and determined visually and qualitatively.
Ethical approval
An ethical approval was obtained from medical ethics committee in faculty of Medicine and Health Science Aden University. Patients were debriefed about the aims of the study and consent was obtained from all patients participating in the study. Patients were informed that their participation was voluntary, were not obliged to answer question(s) that did not wish to, and their withdrawal from the study at any time will not affect their treatment. The confidentiality of the information obtained was assured and each questionnaire was assigned a code number.
Statistical analysis
Descriptive statistics was undertaken to report participants (patients) characteristics.
Parametric analysis was conducted for normally distributed continuous variables, if
Kolmogorov-Smirnova assumptions met, and presented as mean±standard deviation (M±SD).
None parametric analysis was presented for none normally distributed variables and presented as median with range. Categorical variables were presented as numbers (N) with percentages.
Factors associated with LVH (concentric, eccentric), LVD and LV systolic dysfunction were explored in bivariate analysis using both parametric and none parametric (Unpaired T tests, be associated with pressure and volume/flow overload in a form of hypertension, anaemia, arteriovenous fistula and sodium and water retention (15, 16) . Studies showed that higher systolic and diastolic blood pressure and interdialysis weight gain is strongly related to higher LVMI.
In some hemodialysis patients LVD in response to chronic volume/flow overload is an independent factor for progressive LV hypertrophy (17) . Some studies show that volume control, a predictor of increasing systolic blood pressure, lead to regression of LVH (16, 18 ).
In the present study, concentric LV hypertrophy was only significantly associated with systolic hypertension consistent with a study that found progressive LV hypertrophy in haemodialysis patients associated with hypertension but not to other risk factors including anaemia(19). According to this research, anaemia, was not significantly correlated with LVH, which is inconsistent with other study (20). According to this study, LV diastolic dysfunction was predominant among ESRD patients (48.57%). In one study that used novel echo-measurement, higher prevalence of LV diastolic dysfunction was found (48% vs. 39%) compared to more conventional one (26) .
Diastolic dysfunction may be the cause of heart failure with normal systolic function in a large number of haemodialysis patients and is the cause of morbidity and mortality (26) . Heart valve calcification was observed in 46 (43.81%) and valve dysfunction was seen in 52 patients (49.52%) of study group which is in accordance with other studies(27, 28) Calcium deposit, atherosclerosis and other traditional as well as uremia related risk factors may play a role.
Study limitations
This study has some limitations. Abnormal echocardiography findings of left ventricle in this group of population may not reflect a cause effect relationship because of cross-section design of this study. Also, this was a healthcare based study, and the results cannot be generalized to general population. In this study coronary artery disease was not significantly associated with left ventricular disorders. This is may be explained by the fact that most of CAD occurs at micro-arterial circulation. In addition the presence of diastolic heart failure in this group of patients was not mentioned as clinical examination was not the subject of this study.
However, the findings of this study make some sense that ESRD patients manifest a variety of left ventricular structural and functional disorders and its significant association with systolic hypertension and anaemia. As the patient were assessed during the haemodialysis period, the authors of this study feel that haemodialysis services need to be improved to facilitate follow up of the patient serially with echo-study starting at initiation of dialysis and at least biannually thereafter in order to get a clear cardiac prognostic window about patient's evaluation in relation to end stage renal diseases.
CONCLUSION
The present study shows high prevalence of left ventricular echo-cardio-graphic abnormalities in patients of ESRD on maintenance haemodialysis. Left Ventricle (LV) hypertrophy occurs more frequently and only significantly related to systolic hypertension while LV dilatation significantly associated with anaemia. This study calls for further research to identify other important factors with great impact on cardiac status of ESRD patients on haemodialysis program.
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